(IN BRIEF) Sanofi has completed its purchase of Blueprint Medicines, acquiring the approved systemic mastocytosis therapy Ayvakit/Ayvakyt (avapritinib), along with two pipeline candidates: elenestinib (a KIT D816V inhibitor in Phase 2/3 HARBOR, NCT04910685) and BLU‑808 (a wild‑type KIT inhibitor). The $129.00‑per‑share … Read the full press release
Posted in Business, Financial, France, Government, Healthcare, Industrial, Investment, Management, Marketing, News, Pharma & Biotech, Science, Security & Safety, Technology
Tagged $129.00 per share, avapritinib, Ayvakit, Ayvakyt, Blueprint Medicines, BLU‑808, contingent rights, elenestinib, GIST, HARBOR, KIT inhibitor, MERGER, NASDAQ delisting, NCT04910685, partnership, PDGFRA D842V, Sanofi, SM, sustainability, systemic mastocytosis, tender offer
Supplied radio and core network plus services for network upgrade NSN’s comprehensive LTE infrastructure and refarming services helped Telkomsel provide LTE services for Bali APEC summit Jakarta, Indonesia, 6-1-2014 — /EuropaWire/ — Customers of Telkomsel, Indonesia’s largest telecom operator, now enjoy higher … Read the full press release
Posted in Business, Finland, Internet & Online, Technology, Telecom
Tagged 3G HSPA+ network, 3G network, 4G LTE services, Adita Irawati, Alex J. Sinaga, Bali APEC summit, Circuit Switched Fall-Back, Cordia So, Evolved Packet Core, Flexi Multiradio Base Station, Indonesia, Indonesia’s first public LTE services, Indonesia’s largest telecom operator, Jakarta, LTE infrastructure, Nokia Solutions and Networks (NSN), SM, Telkomsel upgrade, ultra-fast mobile broadband
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?